article thumbnail

Measles cases rose 20% worldwide in 2023, per new report

STAT

Measles vaccination coverage globally has still not recovered to pre-Covid levels, a fact that contributed to a 20% increase in measles cases in 2023 over the previous year, according to a new report from the World Health Organization and the Centers for Disease Control and Prevention that was released Thursday.

Vaccines 145
article thumbnail

MSSP ACOs saves Medicare $2.1 billion in 2023, the largest savings in program history

Fierce Healthcare

billion, the largest yearly savings in program history, in 2023, the Centers for Medicare & Medicaid Services revealed on Tuesday. billion, the largest yearly savings in program history, in 2023, the Centers for Medicare & Medicaid Services (CMS) revealed Oct. Accountable care organizations saved Medicare $2.1

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Vaccine Innovation Continued in 2023 with Several Important Approvals

Drug Topics

In 2023, the FDA approved six vaccines, including 2 for respiratory syncytial virus (RSV), and the first vaccine to prevent the mosquito-borne virus chikungunya.

Vaccines 187
article thumbnail

Slideshow: 2023 Biosimilar Approvals

Drug Topics

In addition to the numerous adalimumab (Humira) biosimilars that launched this year, multiple new biosimilar products were approved by the FDA in 2023.

FDA 112
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

Explore the limitations of what we know about prescription drug dosing The future of Clinical Research April 12, 2023 at 11:00 am PDT, 2:00 pm EDT, 7:00 pm GMT Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development?

article thumbnail

CMS: Insurers to make $10.3B in 2023 risk adjustment payments

Fierce Healthcare

The Centers for Medicare & Medicaid Services (CMS) has released new data on risk adjustment payments for 2023. | The Centers for Medicare & Medicaid Services has released new data on risk adjustment payments for 2023.

Insurance 122
article thumbnail

2023 Is the Year for Humira Biosimilars

Drug Topics

As many as 10 Humira biosimilars may be on the US market before 2023 is over. AbbVie has taken several steps to protect its revenues, including the launches of Skyrizi and Rinvoq.

187
187